ASTELLAS PHARMA INC. Tokyo, March 1, 2016 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka) today announced the personnel changes and organizational change as below.
-
Appointment of Corporate Executive effective on April 1, 2016
Name
New Title
Current Title
Kazunori Okimura
Corporate Vice President, Legal
Corporate Vice President,
Legal & Compliance
-
Personnel Changes effective on April 1, 2016
Name
New Title
Current Title
Catherine J. Wertjes
Head of Ethics & Compliance
Vice President, Legal
Astellas US LLC
Hideki Yamanaka
Vice President,
Head of Ethics & Compliance, Japan
Executive Director, Legal & Compliance
- Organizational Change effective on April 1, 2016
Legal & Compliance
Along with the change of global compliance structure, the organization in Japan, Legal & Compliance will be restructured to Legal and Ethics & Compliance, Japan.
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and
external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at www.astellas.com/en.
###
Contacts for inquiries or additional information Astellas Pharma Inc.
Corporate Communications
TEL: 03-3244-3201 FAX: 03-5201-7473
http://www.astellas.com/en
2
Astellas Pharma Inc. issued this content on 01 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 01 March 2016 05:11:34 UTC
Original Document: http://www.astellas.com/en/corporate/news/pdf/160301_2_Eg.pdf
